- Penetrating Keratoplasty
- Endothelial Keratoplasty
- Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
- Corneal Graft
- Corneal Limbal Stem Cell Transplant
Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is expected to grow at 7.5% CAGR over 2023-2029. Corneal transplant refers to the surgical procedure of replacing a damaged or diseased cornea with a healthy one from a donor. The procedure is commonly known as keratoplasty and is essential for restoring vision in individuals suffering from various corneal diseases and conditions. The market encompasses medical devices, surgical equipment, pharmaceuticals, and other products and services that cater to the growing demand for corneal transplant procedures worldwide.
According to data from reputable sources such as the World Health Organization (WHO) and the American Academy of Ophthalmology (AAO), corneal diseases are a significant cause of visual impairment and blindness globally. It is estimated that approximately 12.7 million people worldwide suffer from bilateral corneal blindness, with cataracts and glaucoma being the leading causes of unilateral corneal blindness. The prevalence of corneal diseases is particularly high in developing countries due to various factors, including limited access to quality eye care services and a higher incidence of infectious eye diseases. Moreover, corneal diseases and injuries can result from various causes, such as trauma, infections, hereditary conditions, and degenerative disorders. Among the most prevalent indications for corneal transplants are keratoconus, Fuchs' endothelial dystrophy, corneal scarring from injuries or infections, and corneal edema. These conditions can lead to severe visual impairment or complete loss of vision, significantly impacting the quality of life for affected individuals. The demand for corneal transplants is expected to increase with the aging global population and the rising prevalence of eye diseases. Technological advancements, including minimally invasive surgical techniques and improved tissue preservation methods, are further driving the growth of the corneal transplant market. Governments and healthcare organizations worldwide are emphasizing the need for increased awareness, early diagnosis, and improved accessibility to corneal transplant procedures, ultimately contributing to better visual outcomes and reducing the burden of corneal diseases on society.
In January 2022, Alcon the leader in eye care dedicated to assisting people in seeing brilliantly, declared the closing of its formerly announced acquisition of Ivantis, creator of the novel Hydrus microstent, a minimally invasive glaucoma surgery (MIGS) instrument created to lower eye pressure for open-angle glaucoma patients in association with cataract surgery.
Fastest Growing Market
The corneal transplant market is experiencing significant growth due to various driving factors and promising opportunities. One of the key growth drivers is the increasing prevalence of corneal diseases and conditions worldwide, leading to a higher demand for transplant procedures. Technological advancements in corneal transplantation techniques, such as Descemet's stripping automated endothelial keratoplasty (DSAEK) and femtosecond laser-assisted procedures, have improved surgical outcomes and patient recovery, further boosting the market. Additionally, the aging global population has resulted in a rise in age-related eye disorders, contributing to the market's expansion. Moreover, the growing awareness about eye health and the availability of advanced eye care facilities are increasing the number of patients opting for corneal transplants. Furthermore, favorable government initiatives and funding for promoting eye health and organ donation programs are creating new opportunities for market growth. As the healthcare sector continues to evolve, with a focus on regenerative medicine and tissue engineering, the corneal transplant market is expected to witness even more significant advancements and opportunities in the coming years.
The corneal transplant market was valued at USD 455.8 million in 2022 and is expected to grow at 7.5 % CAGR over the forecast period 2023 – 2029.
The key opportunities for the corneal transplant market include advancements in surgical techniques, regenerative medicine, and tissue engineering, coupled with increasing awareness and government support for eye health and organ donation programs.
The key trends in the corneal transplant market include a shift towards minimally invasive procedures, the adoption of advanced surgical technologies, the increasing use of pre-cut corneal tissue, and a growing focus on personalized medicine approaches.
CryoLife, Inc., Exactech, Inc., Kohler GmbH, Lifeline Scientific, AbbVie Inc., Medtronic, Organogenesis Inc., Alabama Eye Bank, and Alcon are a few prominent companies operating in the field of Corneal Transplant market.